Live
- All you need to know about PAN 2.0
- Akasa Air redefines travel experience with industry-first offerings
- MP: Residents stage protests against liquor shop in Indore
- Telugu Actor Shri Tej Booked for Alleged Cheating and False Promise of Marriage in Live-in Relationship
- Toyota Kirloskar Motor Celebrates 1 Lakh Urban Cruiser Hyryder on Indian Road
- MLS: New York City FC part ways with head coach Nick Cushing
- Delhi CM says Centre cutting AAP voters’ names from rolls, BJP hits back
- Hyderabad Metro Rail Phase-II Works to Begin in Old City in January 2025
- Odisha: 668 persons killed in human-elephant conflicts in last three years
- DEFENDER JOURNEYS: TO EMBARK ON ITS THIRD EDITION FROM NOVEMBER 2024
Hyderabad: Pharma firm MSN Group offers free Corona medicine to corona warriors
Pharma firm MSN Group offers free Corona medicine to corona warriors
Pharmaceutical company MSN Group (MSN) has announced free Favilow tablets to corona warriors including doctors, nurses, journalists, police & sanitation personnel across 170 cities if tested Covid-19 positive
Hyderabad: Pharmaceutical company MSN Group (MSN) has announced free Favilow tablets to corona warriors including doctors, nurses, journalists, police & sanitation personnel across 170 cities if tested Covid-19 positive.
MSN will distribute free Favilow 200 mg tablets (Favipiravir) as an attempt to salute the selfless spirit of doctors, nurses, journalists, police & sanitation personnel. They can avail the benefit by providing the test report, doctor's prescription, and work ID at the customer care desk for free delivery of the drug, the company said in a statement.
Dr MSN Reddy, CMD, MSN Group, said "We want to express our solidarity with all the front-line fighters for displaying exemplary service during this pandemic situation. We feel as an organisation it is our responsibility to acknowledge & to service all the brave hearts," he said.
The drug 'Favipiravir' has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of Covid-19 in adults and children, hospitalised with mild to moderate symptoms of the disease.
